Objective: To report trends of extended spectrum β-lactamase (ESBL), multidrug resistant (MDR) ESBL and AmpC producing isolates of K. pneumoniae from MGM Hospital, kamothe. Navi Mumbai. Methods: Multidrug resistance, ESBL & AmpC production was tested by confirmatory methods as per Clinical Laboratory Standard Institute (CLSI) guidelines. Results:-Out of 1670 sample (urine, pus and ET-secretion) 89(5.32%) klebsiella strain were isolated among them 57(64%) were MDR strains resistance to ceftizoxime 80%, cefuroxime 80%, tetracycline 78%, cefaperazone 75%,ceftazidime 70%. Among these isolates higher prevalence of ESBL and AmpC production was observed in ET-secretion 46.66% and 20% followed by urine 35% and 11.7% and pus 32%.and 8%. Conclusion:-Detection for the ESBL and AmpC should be carried out as a routine it is simple and cost effective test to improve infections control practices to avoid irrational use of antibiotics and empirical regime should be revisited to prevent further resistance
Introduction:
In 1883 Friedlander isolated a capsulated bacillus from the lungs of patient who died of pneumonia. This was named after him as Friedlander's bacillus. Later on this organism was given the generic name of Klebsiella, which is ubiquitously present and reported worldwide. Strains of Klebsiella are responsible for a wide variety of diseases in humans. These bacteria have become important pathogens in nosocomial infections . (1) In addition to being the primary cause of respiratory tract infections like pneumonia, rhinoscleroma, ozaena, sinusitis and otitis, it also causes infections of the alimentary tract like enteritis, appendicitis and cholycystitis. They are frequently associated with the infections of urinary tract, genital tract, and the eyes . (2) Extended spectrum β-lactamases (ESBLs) are plasmid-mediated bacterial enzymes that confer resistance to the penicillins (except temocillin), first-, second-, and third generation cephalosporins, and aztreonam (but not the cephamycins or carbapenems) and are inhibited by β-lactamase inhibitors such as clavulanic acid .(3) AmpC β-lactamases are Group I cephalosporinases that confer resistance to a wide variety of β-lactam antibiotics including alpha methoxy β-lactams such as cefoxitin, narrow and broad spectrum cephalosporins, aztreonam, and are poorly inhibited by β-lactamase inhibitors such as clavulanic acid .(4) During treatment with β-lactams, resistant mutants showing constitutive high levels of AmpC production are frequently selected leading to therapeutic failures.
(5). In India high prevalence of ESBL producing Klebsiella strains has been reported by various groups. Reported frequency of ESBL producing Klebsiella species from India ranged between 13 to 87%. (6, 7, 8, 9, 10, 11, 12) Materials and Methods:-Bacterial isolates:-A total of 89 consecutive, non-repeat clinical isolates of a Klebsiella strain was collected from Department of Microbiology, MGM Hospital Kamothe, Navi Mumbai, over a period of one year. (Feb 2012 to Feb 2013 , both the outpatients and inpatients were included in the study. The isolates were obtained from different clinical specimens such as ET-secretion in case of ventilated associated pneumonia (VAP), 100 microliter of the homogenized sample was added to 100 ml of sterile normal saline definitive diagnosis of VAP, quantitative culture threshold was considered as 10 4 CFU/ml. Growth of any organism below the threshold were assumed to be due to colonization or contamination . (13, 14) Urine for urine tract infection (UTI) and pus for wound cases by bacteriological conventional methods
.(15)
Antimicrobial Sensitivity Testing: The antimicrobial sensitivity test of the isolates was carried out as described by the KirbyBauer disc diffusion method on Muller Hinton agar according to CLSI protocols. (16) Isolates were labelled as MDR if they were resistant to at least two classes of first line agents including ampicillin, trimethoprim-sulfamethoxazole, floroquinolones (ciprofloxacin and ofloxacin), gentamicin and cephalosporins (cephotaxime, ceftriaxone and ceftazidime). (17) The drugs tested were Ampicillin (10μg), amoxicillin clavulanic acid (20 / 10μg), piperacillin (100μg) piperacillin-tazobactam (100/10μg), cephotaxime (30μg), ceftriaxone (30μg), ceftazidime (30μg), cefpodoxime (10μg), gentamicin (10μg), amikacin (30μg) ciprofloxacin (5μg), tetracycline (30μg), chloramphenicol (30μg), trimethoprim-sulfamethoxazole (1.25 / 23.75μg) and imipenem (10μg). E. coli ATCC 25922 was used as control strains.
ESBL detection:-National Committee for Clinical Laboratory Standard (NCCLS) Phenotypic confirmatory combination disc diffusion test. A disc of ceftazidime (30μg) alone and ceftazidime + clavulanic acid (30μg/10) were placed at a distance of 25 mm centre to centre on a MHA plate inoculated with a bacterial suspension of 0.5 McFarland turbidity standards and incubated overnight at 37˚C. An increase in inhibition zone diameter of ≥5mm for a combination disc versus ceftazidime disc alone confirmed ESBL producer. .Klebsiella pneumoniae ATCC 760063 was used as control strain (18) AmpC detection:-All isolates were tested for AmpC β-lactamase production on discs containing boronic acid. A disc containing 30 μg of cefoxitin and another containing 30 μg of cefoxitin with 400 μg of boronic acid was placed on the agar. Inoculated plates incubated overnight at 37°C. An organism demonstrating a zone diameter around the disk containing cefoxitin and boronic acid ≥5 mm than the zone diameter around the disk containing cefoxitin alone were considered an AmpC producer . (19) Results and Discussion:-Table no 1. Shows prevalence of Klebsiella species (5.32%) highest was shown by ET-secretion (20%) followed by pus (5.56%), and urine (3.08%). Whereas study by Kritu panta et all. shows prevalence of Klebsiella species (8.8%), urine (9.6%), pus (28.57%). (23) This study shows prevalence of Multidrug resistance (64.04%) highest was shown by ET-secretion (79.16%) followed by pus (60%) and urine (55.55%). This finding is much higher than a report by Shayam Kumar Mishra, (23.4%) in the same setting (24) . In case of wound swab by Girma Godema et all. was (69.6%).
(25) Table 2 shows that Klebsiella isolates were from patients of which 27(61.7%) were males and 30(38.20%) were females.The male:female ratio was 0. Table 3 Shows the prevalence of ESBL and AmpC as found in Klebsiella species isolated from the various clinical specimens. Prevalence of total ESBL was 36.84%, highest prevalence was seen in ET-secretion 7(46.66%), followed by urine 6(35.22%), pus 8(32%). Shamweel Ahmad et al. showed 10.4% prevalence of ESBL producing Klebsiella. The highest prevalence of ESBL was seen in ET-secretion (25%) followed by wound swabs (13.9%) and urine (9.2%).
(28) Laghawe Avinash R. et all. showed 11.7% prevalence of AmpC in Klebsiella species. (29) Table 6 shows that out of 89 Klebsiella isolates the maximum resistance was observed in case pus to cephotaxime 80%, cefaperazone 75% and ceftazidime 70%. Urine was resistance to ceftizoxime 70%, tetracycline 78%, ampicillin/ sulbactum 65%. and ET-secretion was cefuroxime 80%, cephotaxime 75% and cefaperazone 66%.Savita Jadhav et all. was shown maximum resistance to amoxicillin 82.59% followed by tetracycline 82%, cotrimoxazole 80%, ceftazidime 77.89% cephotaxime 57.97%, gentamicin 53.76%, ciprofloxacin 52.52%amikacin 41.78% and ceftriaxone 41.36% (30) Conclusion:-Antimicrobial resistance is a global concern not only because it kills but because it increases health costs and threatens patient care In this study, Klebsiella species was found to be the most predominant isolates as a cause of urinary tract infections, ventilated associated pneumonia and wound infection and also showed a very high prevalence of MDR. In case of wound shows resistance to ceftizoxime 80%, urine tract infection, tetracycline 78% and ventilated associated pneumonia, cefuroxime 80%. Among these isolates higher prevalence of ESBL and AmpC production was observed in ET-secretion 46.66% and 20% followed by urine 35% and 11.7% and pus 32%.and 8%. It is concluded that detection for the ESBL and AmpC should be carried out as a routine it is simple and cost effective test. MDR K. pneumoniae play a crucial role in spreading UTI, VAP and wound. Now, it is the need to improve infections control practices, avoid irrational use of antibiotics and empirical regime should be revisited to prevent further resistance.
